Search Within

Jennifer Lynn Sauter

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (18)
  2. Meeting Abstract (9)
Groups
  1. Department of Pathology and Laboratory Medicine (27)
  2. Sloan Kettering Institute Postdocs (27)
  3. GSK Faculty (25)
  4. Department of Medicine (23)
  5. Solid Tumor Oncology Division (23)
  6. Thoracic Oncology (23)

More Groups

People
  1. Marc Ladanyi (14)
  2. Charles Rudin (13)
  3. William Travis (13)
  4. Natasha Rekhtman (12)
  5. Jason Chang (11)
  6. Hira Rizvi (10)

More People

Years
  1. 2025 (1)
  2. 2024 (6)
  3. 2023 (1)
  4. 2022 (3)
  5. 2020 (8)
  6. 2018 (8)
Publications
  1. Modern Pathology (5)
  2. Journal of Clinical Oncology (4)
  3. Journal of Thoracic Oncology (4)
  4. Cancer Cell (3)
  5. Clinical Cancer Research (3)
  6. American Journal of Surgical Pathology (1)

More Publications

Publishers
  1. Nature Research (6)
  2. American Association for Cancer Research (5)
  3. American Society of Clinical Oncology (4)
  4. Elsevier Inc. (4)
  5. Cell Press (3)
  6. Biomed Central Ltd (1)

More Publishers

Results (27)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Type A thymoma presenting with bone metastasis
    Journal Article

    Montecalvo, J.; Chang, J.; Rekhtman, N.; Antonescu, C. R.; Bains, M. S.; Fabbri, N.; Plodkowski, A. J.; Riely, G. J.; Travis, W. D.; Sauter, J. L.
    Histopathology (2018)

    Fulltext@MSK | Save
  • Bronchiolar adenoma: Expansion of the concept of ciliated muconodular papillary tumors with proposal for revised terminology based on morphologic, immunophenotypic, and genomic analysis of 25 cases
    Journal Article

    Chang, J. C.; Montecalvo, J.; Borsu, L.; Lu, S.; Larsen, B. T.; Wallace, W. D.; Sae-Ow, W.; Mackinnon, A. C.; Kim, H. R.; Bowman, A.; more...
    American Journal of Surgical Pathology (2018)

    Fulltext@MSK | Save
  • Genomic features of response to combination immunotherapy in patients with advanced non-small-cell lung cancer
    Journal Article

    Hellmann, M. D.; Nathanson, T.; Rizvi, H.; Creelan, B. C.; Sanchez-Vega, F.; Ahuja, A.; Ni, A.; Novik, J. B.; Mangarin, L. M. B.; Abu-Akeel, M.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • SMARCA4 (BRG1) deficiency in lung carcinomas correlates with poor differentiation and aggressive clinical behavior
    Meeting Abstract

    Montecalvo, J.; Alex, D.; Ptashkin, R.; Ni, A.; Sauter, J. L.; Chang, J.; Beras, A.; Namakydoust, A.; Rudin, C.; Ladanyi, M.; more...
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Pulmonary BRG1 (SMARCA4)-deficient undifferentiated neoplasms represent an exceptionally aggressive type of sarcomatoid carcinoma: Clinicopathologic and genomic evidence supports a link to non-small cell carcinoma
    Meeting Abstract

    Montecalvo, J.; Alex, D.; Ptashkin, R.; Ni, A.; Sauter, J. L.; Chang, J.; Jungbluth, A.; Beras, A.; Namakydoust, A.; Rudin, C.; more...
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Comparison of MTAP immunohistochemistry (IHC) with p16/CDKN2A deletions/loss and utility of MTAP and BAP1 IHC in the diagnosis of malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Shahi, M.; Eguchi, T.; Zauderer, M.; Travis, W.; Jungbluth, A.; Frosina, D.; Fayad, M.; Asher, M.; Adusumilli, P. S.; Ladanyi, M.; more...
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Molecular determinants of response to anti-programmed cell death (PD)-1 and anti-programmed death-ligand 1 (PD-L1) blockade in patients with non-small-cell lung cancer profiled with targeted next-generation sequencing
    Journal Article

    Rizvi, H.; Sanchez-Vega, F.; La, K.; Chatila, W.; Jonsson, P.; Halpenny, D.; Plodkowski, A.; Long, N.; Sauter, J. L.; Rekhtman, N.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save